Upcoming webinar: Speech as a biomarker in Ataxia: What can it tell us & how should we use it?


E2di2R_XMAA02Cl.jpgRedenlab CSO, Adam Vogel, will be presenting at the upcoming joint webinar with the European Reference Network for rare or low prevalence complex diseases, Neurological Diseases (ERN-RND), Neuromuscular Dieseases (ERN EURO-NMD), and European Academy of Neurology. The subject of the webinar is Speech as a biomarker in Ataxia: What can it tell us & how should we use it. Sign up here!

Related Post

  • Posted on 14 September, 2023
    Redenlab, a leading provider of innovative solutions in the field of pediatric and neurodevelopment communication, proudly announces that Professor Angela...
    • Posted on 11 August, 2023
      Dentatorubral-pallidoluysian atrophy (DRPLA) is a rare progressive brain disorder that can impact children and adults. In children, DRPLA can lead...
      • Posted on 13 July, 2023
        Redenlab are thrilled to announce that Dr. Peter Gibilisco has joined Redenlab's advisory board. As a consumer advisor with profound...